\
Topic Area
Marker Type
Project Status
Steering Committee
Government Entities
Precision Dosimetry Imaging Biomarker (PDIB)
Publications
The relationship between baseline bone mineral density and fracture incidence in the placebo groups of randomized controlled trials using individual patient data from the FNIH-ASBMR-SABRE project
Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA
Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury
ADNI Biomarker Core: A review of progress since 2004 and future challenges
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Measurable Residual Mutated NPM1 before Allogeneic Transplant for Acute Myeloid Leukemia
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
Show More

Diseases

Learn more about the diseases we fight

Partner With Us

Work with the FNIH to accelerate medical breakthroughs for patients